These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 7542572

  • 1. Complement inhibition by human vitronectin involves non-heparin binding domains.
    Sheehan M, Morris CA, Pussell BA, Charlesworth JA.
    Clin Exp Immunol; 1995 Jul; 101(1):136-41. PubMed ID: 7542572
    [Abstract] [Full Text] [Related]

  • 2. Vitronectin-mediated inhibition of complement: evidence for different binding sites for C5b-7 and C9.
    Milis L, Morris CA, Sheehan MC, Charlesworth JA, Pussell BA.
    Clin Exp Immunol; 1993 Apr; 92(1):114-9. PubMed ID: 7682159
    [Abstract] [Full Text] [Related]

  • 3. The heparin binding domain of S-protein/vitronectin binds to complement components C7, C8, and C9 and perforin from cytolytic T-cells and inhibits their lytic activities.
    Tschopp J, Masson D, Schäfer S, Peitsch M, Preissner KT.
    Biochemistry; 1988 May 31; 27(11):4103-9. PubMed ID: 2458130
    [Abstract] [Full Text] [Related]

  • 4. Clusterin, the human apolipoprotein and complement inhibitor, binds to complement C7, C8 beta, and the b domain of C9.
    Tschopp J, Chonn A, Hertig S, French LE.
    J Immunol; 1993 Aug 15; 151(4):2159-65. PubMed ID: 8345200
    [Abstract] [Full Text] [Related]

  • 5. A synthetic peptide from complement protein C9 binds to CD59 and enhances lysis of human erythrocytes by C5b-9.
    Tomlinson S, Whitlow MB, Nussenzweig V.
    J Immunol; 1994 Feb 15; 152(4):1927-34. PubMed ID: 7509832
    [Abstract] [Full Text] [Related]

  • 6. Recombinant C345C and factor I modules of complement components C5 and C7 inhibit C7 incorporation into the complement membrane attack complex.
    Thai CT, Ogata RT.
    J Immunol; 2005 May 15; 174(10):6227-32. PubMed ID: 15879120
    [Abstract] [Full Text] [Related]

  • 7. S-protein/vitronectin interaction with the C5b and the C8 of the complement membrane attack complex.
    Su HR.
    Int Arch Allergy Immunol; 1996 Aug 15; 110(4):314-7. PubMed ID: 8768797
    [Abstract] [Full Text] [Related]

  • 8. Potent inhibition of terminal complement assembly by clusterin: characterization of its impact on C9 polymerization.
    McDonald JF, Nelsestuen GL.
    Biochemistry; 1997 Jun 17; 36(24):7464-73. PubMed ID: 9200695
    [Abstract] [Full Text] [Related]

  • 9. H19, a surface membrane molecule involved in T-cell activation, inhibits channel formation by human complement.
    Whitlow MB, Iida K, Stefanova I, Bernard A, Nussenzweig V.
    Cell Immunol; 1990 Mar 17; 126(1):176-84. PubMed ID: 1689219
    [Abstract] [Full Text] [Related]

  • 10. Formation of the terminal complement complex on agarose beads: further evidence that vitronectin (complement S-protein) inhibits C9 polymerization.
    Johnson E, Berge V, Høgåsen K.
    Scand J Immunol; 1994 Mar 17; 39(3):281-5. PubMed ID: 7510414
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the lytic action of cell-bound terminal complement components by human high density lipoproteins and apoproteins.
    Rosenfeld SI, Packman CH, Leddy JP.
    J Clin Invest; 1983 Apr 17; 71(4):795-808. PubMed ID: 6403580
    [Abstract] [Full Text] [Related]

  • 12. Molecular organization of C9 within the membrane attack complex of complement. Induction of circular C9 polymerization by the C5b-8 assembly.
    Podack ER, Tschoop J, Müller-Eberhard HJ.
    J Exp Med; 1982 Jul 01; 156(1):268-82. PubMed ID: 6177822
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Role of a disulfide-bonded peptide loop within human complement C9 in the species-selectivity of complement inhibitor CD59.
    Husler T, Lockert DH, Sims PJ.
    Biochemistry; 1996 Mar 12; 35(10):3263-9. PubMed ID: 8605162
    [Abstract] [Full Text] [Related]

  • 15. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9.
    Rollins SA, Sims PJ.
    J Immunol; 1990 May 01; 144(9):3478-83. PubMed ID: 1691760
    [Abstract] [Full Text] [Related]

  • 16. Complement component C7 is a plasminogen-binding protein.
    Reinartz J, Hänsch GM, Kramer MD.
    J Immunol; 1995 Jan 15; 154(2):844-50. PubMed ID: 7814888
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Calcium-loaded erythrocytes have a defect in complement regulation distinct from that resulting from exposure to 2-aminoethylisothiouronium bromide.
    Test ST, Mitsuyoshi J.
    Blood; 1995 Oct 01; 86(7):2799-806. PubMed ID: 7545473
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.